Gabapentin Capsule
Product Images NDC 71610-185

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71610-185). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 185 mg (71610 0185 30)

This is a product description for a medicine called Gabapentin USP, which comes in a package of 30 capsules. The NOC# is also provided for reference.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1 (Gabapentin Capsules Fig01)

This is a chart showing mean pain scores during a 4-week dose titration period and a 4-week fixed dose period for patients taking either a placebo or gabapentin at a dosage of 3600 mg/day. The chart includes baseline measurements and measurements taken on weeks 1-8.*

FDA Label Image

Figure 2 (Gabapentin Capsules Fig02)

FDA Label Image

Figure 3 (Gabapentin Capsules Fig03)

This appears to be a graph showing the proportion of responders (patients with more than 50% reduction in pain score) at endpoint for two controlled PHN studies. One study had a 29% response rate and the other had a 32% response rate. The graph also includes percentages ranging from 100% to 0%, with increments of 10%. There are two labels on top of the graph indicating statistical significance at p<0.01 and p<0.001. Other than the graph, there are also some prices listed in GBP for PBO and GBP 3600 and different levels of GBP for the other data, although the context and relevance of these prices are not clear.*

FDA Label Image

Figure 4 (Gabapentin Capsules Fig04)

FDA Label Image

Formula (Gabapentin Capsules Formula)

This is a formula used to calculate the estimated creatinine clearance of a patient, measured in mL/min. The formula takes into account the patient's age, weight, and serum creatinine levels. It also includes a multiplier of 0.85 for female patients. This calculation is commonly used to determine kidney function and to adjust medication dosages for patients with kidney disease.*

FDA Label Image

Structural Formula (Gabapentin Capsules Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.